The Cancer Insurance Gap in Southeast Asia: Why Traditional Policies Are Failing Patients

Over 70% of cancer diagnoses across Southeast Asia occur at Stage 3 or 4 — precisely when treatment is most expensive and most effective. This analysis examines why conventional insurance products fail these patients and how Cancer Precision Medicine insurance provides a structural solution.

The information contained in this article is for general information and educational purposes only. It does not constitute financial, investment, or insurance advice. Beacon Global Risk Solutions Limited is licensed by the Labuan Financial Services Authority (Licence No. BS2025152) as a reinsurance and insurance broker. This content is intended for licensed insurance professionals and institutional parties.